- Introduction: What Can Statistical Gene Lists Tell Us, and What Can They Not?
Every time I complete an RNA-seq analysis in the laboratory or in front of a computer screen and look at those massive differential gene expression (DGE) tables handed to me, I ask myself the same question: How much of the real biological story unfolding inside the cell does this list of hundreds of genes actually tell? Popular tools such as DESeq2 or edgeR provide us with very clear statistical metrics such as log2 fold change (log2FC) and adjusted p-values (FDR) following library depth normalization. However, as I frequently observe in my own analytical experience, declaring a gene the "center" of a biological response simply because its p-value is very low is a major illusion. When we apply rigid cutoff thresholds (for example, FDR < 0.05 and |log2FC| > 1), we discard with our own hands key genes that play a vital role in cellular processes but exhibit only subtle shifts in expression. In my view, the most fundamental breaking point lies here. Classical DGE tests each gene in isolation from one another. This causes us to conflate "driver" genes, which directly initiate biological change, with passive "passenger" genes that are merely swept along by the storm. Frankly, many master transcription factors and receptors that govern the cell can command the entire process even when their mRNA levels do not change at all (Non-DEGs). For this reason, I believe we should view raw gene lists not as a final result on their own, but merely as initial clues to be investigated.
- Current Methods: Our Efforts to Contextualize Gene Lists
When we turn to our bioinformatics toolbox to break the silence created by gene lists, we encounter four fundamental approaches that illuminate the data from different angles. Over-Representation Analysis (ORA) offers us a rapid, macro-level bird’s-eye view by testing whether our filtered genes cluster within known biological pathways beyond random expectation. However, in my own work, when I find the rigid, threshold-bound nature of ORA insufficient, I turn to threshold-free Gene Set Enrichment Analysis (GSEA); indeed, GSEA is far more successful at capturing small but coordinately acting gene groups across the entire genome list, as well as the "leading-edge" genes driving the process. Of course, neither ORA nor GSEA reveals the directed hierarchy among genes. At this point, Gene Regulatory Networks establish the control links between transcription factors and target genes, bringing to light the master regulators that conduct the orchestra even while their own expression remains stable. Finally, when I integrate Protein–Protein Interaction networks, I can map the physical complexes formed by gene products inside the cell and identify key hub proteins. In my eyes, none of these methods is a "magic wand" on its own; however, when brought together, they transform into complementary pieces that impart biological meaning to raw data.
- Critical Evaluation: Methodological Pitfalls We Risk Falling Into
No matter how fascinating the colorful network maps and sleek graphics generated by bioinformatics tools may look, I am convinced that we must be extremely cautious when interpreting their results. One of the methodological pitfalls I most frequently encounter in the literature and in practical applications is automatically assuming that an enriched pathway is "activated." Yet, the enrichment of a pathway cannot directly prove whether that pathway is biologically functional; positive and negative feedback loops, together with massive pathway definitions in databases, can very easily mislead us into false-positive conclusions. I believe we must frequently remind ourselves of this: The co-variation of two genes in co-expression networks is merely a statistical association; it never carries a direct causal relationship. Furthermore, sample-specific gene length bias arising from technical fluctuations during library preparation, along with small sample sizes, can generate artificial enrichment signals in bioinformatics pipelines. In my view, accepting bioinformatics outputs not as absolute biological realities, but as strong "hypotheses" awaiting experimental testing, is the first prerequisite of scientific integrity.
- Approaching the Mechanism: Transitioning from Predictions to Causal Evidence
What must we do to transform biostatistical predictions on a screen into genuine biological evidence? The lesson I have drawn from my own research and from compelling examples in the literature is this. Although repeating a finding across independent cohorts (cross-cohort replicability) increases statistical reliability, it does not by itself prove biological causality. Orthogonal experimental validations such as RT-qPCR are certainly valuable for eliminating bioinformatics noise. However, if we wish to leap from correlation to causation, we must actively perturb the system. Scalable CRISPRi/a-based technologies (Perturb-seq, TAP-seq) and gene knockdown/knockout studies allow us to deliberately disrupt a target gene and directly measure the downstream transcriptomic response. Moreover, the pronounced discrepancy between mRNA abundances and final protein and metabolite levels continually shows me one thing: We cannot complete the cellular story by looking solely at the transcriptomic layer. The moment we integrate the transcriptome with proteomic and metabolomic layers, we can bridge molecular regulation with the ultimate biochemical outcome.
- Future Perspective and Conclusion: The Journey from Description to Systems Biology
Today, we are witnessing the field of transcriptomics transition from a descriptive stage that merely lists cellular states to a systems biology stage that decodes the dynamic and causal control mechanisms governing those states. Single-cell RNA sequencing and spatial transcriptomics approaches lay bare intra-tissue heterogeneity and intercellular communication networks without disrupting spatial architecture. Even more excitingly, by moving from static gene networks to cellular-level causal models and generative artificial intelligence simulations, we are becoming capable of predicting the effects of untested gene perturbations on a computer. Ultimately, the value of transcriptomic data will be measured not by the length of the statistical gene lists we generate, but by the extent to which we can explain what these changes mean for cellular fate and disease mechanisms through independent, causal, and spatial evidence.
REFERENCES
Baruri, A., et al. (2026). Integrative epigenomics: Bioinformatics strategies for multi-omics data analysis in health and disease. Frontiers in Genetics, 17, 108492.
Bowen, Z., Su, T. Y., Wang, J., Islam, Q. S., Song, K., Huang, S. K., Allez, M., Fonseca, G. J., Baglole, C. J., & Ding, J. (2025). DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. Nucleic Acids Research, 53(22), gkaf1350.
Cen, X., Huang, X., Deng, E., Gong, X., Tan, N., Ye, J., Wang, Y., Eils, R., Luo, Q., Li, Y., & Qu, F. (2026). Single-cell and spatial omics: Methods and applications. MedComm, 7(1), e2026.
Cheng, C., Chen, W., Jin, H., & Zhang, J. (2023). A review of single-cell RNA-seq annotation, integration, and cell-cell communication. Cells, 12(15), 1970.
Christensen, A., et al. (2026). Causal effect estimation from trans-regulatory single-cell CRISPR screens. bioRxiv, 2026.04.12.589102.
Degen, P. M., & Medo, M. (2025). Replicability of bulk RNA-Seq differential expression and enrichment analysis results for small cohort sizes. PLOS Computational Biology, 21(5), e1011630.
Gu, J., Skelton, A., Staley, J., Popson, P., Peng, L., Song, X., Knowles, J., & He, Z. (2026). Distilling direct effects via conditional differential gene expression analysis. Bioinformatics, 42(1), btae750.
Hoerbst, F., Sidhu, G. S., Tomkins, M., & Morris, R. J. (2025). What is a differentially expressed gene? bioRxiv, 2025.01.31.635902.
Karp, P. D., Midford, P. E., Caspi, R., & Khodursky, A. (2021). Pathway size matters: the influence of pathway granularity on over-representation (enrichment analysis) statistics. BMC Genomics, 22(1), 191.
Maizels, R. J., & Briscoe, J. (2026). Gene regulatory networks: from correlative models to causal explanations. Nature Reviews Genetics, 27(6), 485–498.
Mandelboum, S., Manber, Z., Elroy-Stein, O., & Elkon, R. (2019). Recurrent functional misinterpretation of RNA-seq data caused by sample-specific gene length bias. PLOS Biology, 17(11), e3000481.
Marini, A., Fédérico, A., et al. (2021). GeneTonic: an R/Bioconductor package for streamlining the interpretation of RNA-seq data. BMC Bioinformatics, 22(1), 610.
McDermaid, A., Chen, X., Zhang, Y., Wang, C., Zhang, J., & Ma, Q. (2019). Interpretation of differential gene expression results of RNA-seq data: review and integration. Briefings in Bioinformatics, 20(6), 2044–2054.
Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010). Enrichment Map: A network-based method for gene-set enrichment visualization and interpretation. PLOS ONE, 5(11), e13984.
Moonen, J. P., et al. (2026). Targeted single-cell RNA and perturbation sequencing with TAP-seq. Nature Methods, 23(3), 412–421.
Olivas-Bernal, R., et al. (2026). Transcriptomic meta-framework for robust cross-study biological inference. Human Genetics, 145(2), 112–128.
Rajkumar, A. P., et al. (2015). Experimental validation of methods for differential gene expression analysis and sample pooling in RNA-seq. BMC Genomics, 16(1), 548.
Ranalli, M. G., et al. (2026). A statistical framework for measuring reproducibility and replicability of high-throughput experiments from multiple sources. Biometrics, 82(1), ujaf012.
Rosati, D., Palmieri, M., Brunelli, G., Morrione, A., Iannelli, F., Frullanti, E., & Giordano, A. (2024). Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review. Computational and Structural Biotechnology Journal, 23, 1154–1168.
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550.
Thummar, R., et al. (2026). Integrating transcriptomics and metabolomics for clinical disease detection: A critical review of emerging diagnostic methodologies. TrAC Trends in Analytical Chemistry, 184, 118120.
Wang, X., Chen, J., & Zhang, Y. (2026). CSCN: inference of cell-specific causal networks using single-cell RNA-seq data. Bioinformatics, 42(2), btae890.
Williams, C. G., Lee, H. J., Asatsuma, T., Vento-Tormo, R., & Haque, A. (2022). An introduction to spatial transcriptomics for biomedical research. Genome Medicine, 14(1), 68.
Zhang, Z., et al. (2026). inGSEA: An improved method for gene set enrichment analysis using a weighted integral statistic. bioRxiv, 2026.06.02.729106.